|
Quanterix Corporation is developing a novel platform
for single molecule analysis that will bring an unprecedented level
of sensitivity, precision, and assay robustness to clinical diagnostics,
drug development, and life science research. Our unique
approach permits rapid quantification and analysis of individual
proteins and small molecules within complex biological samples, enabling
us to address a variety of unmet medical needs. Founded
in 2007, Quanterix is backed by leading life science investors including
ARCH Venture Partners, Bain Capital Ventures, and Flagship Ventures.
|
 |
November 11, 2008 – Press Release
Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board
[ PDF ]
September 30, 2008 – Press Release
Quanterix Corporation Awarded $185,000 Grant from the National Cancer Institute
[ PDF ]
August 25, 2008 – Press Release
Quanterix Corporation Raises $15 Million in Series A Financing
[ PDF ]
May 13, 2008 – In the News
Quanterix featured in the MIT Technology Review "Next Generation Diagnostics"
Career Inquiries: hr@quanterix.com
Other Inquiries: info@quanterix.com
|